The Utility of Telemedicine in the Management of Migraine
2 other identifiers
observational
45
1 country
1
Brief Summary
Patients will be randomly assigned to receive their follow-up care via telemedicine or in-office visits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 10, 2012
CompletedFirst Posted
Study publicly available on registry
October 15, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedResults Posted
Study results publicly available
October 25, 2019
CompletedOctober 25, 2019
September 1, 2019
6 years
October 10, 2012
June 11, 2019
September 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assess the Utility of Telemedicine for Follow-up Care in a Headache Medicine Practice
Percentage of completed scheduled study visits for each group.
One Year
Study Arms (2)
Telemedicine Group
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated via telemedicine for migraine headaches
In-Office Group
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated in the clinician's office for migraine headaches
Eligibility Criteria
Patients must be diagnosed with Migraine Headaches
You may qualify if:
- Diagnosis of migraine with or without aura, menstrual migraine, hemiplegic migraine
- Able to provide informed consent
- Able, in the opinion of the investigator, to reliably perform all aspects of the study
- Ownership of or access to a computer and high speed internet
- Age less than 18 years
- Headache type is not migraine
- No ownership or access to a computer or high speed internet
- Unfamiliar with basic computer operations or uncomfortable using a computer
- Unwilling to participate
- Unable to read English (because of assessment tools)
- History of another medical, psychiatric, social or behavioral problem that, in the opinion of the investigator, makes it unlikely that they will be able to complete the study activities. Questions regarding mood and anxiety are asked of all patients as part of their initial evaluation for headache.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universit of Texas Southwestern
Dallas, Texas, 75390, United States
Related Publications (1)
Friedman DI, Rajan B, Seidmann A. A randomized trial of telemedicine for migraine management. Cephalalgia. 2019 Oct;39(12):1577-1585. doi: 10.1177/0333102419868250. Epub 2019 Aug 26.
PMID: 31450969DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Deborah I. Friedman, MD, MPH, Professor of Neurology and Neurotherapeutics and Ophthalmology
- Organization
- UT Southwestern Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Deborah Friedman, MD
University of Texas Southwestern Medical Center
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Primary Investigator, MD, Neurology and Neurotheraputics
Study Record Dates
First Submitted
October 10, 2012
First Posted
October 15, 2012
Study Start
October 1, 2012
Primary Completion
October 1, 2018
Study Completion
October 1, 2018
Last Updated
October 25, 2019
Results First Posted
October 25, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share